Clinical study of Wenxikeli treatment of viral myocarditis / 中华实验和临床病毒学杂志

ABSTRACT

<p><b>OBJECTIVE</b>To observe Wenxinkeli viral myocarditis clinical efficacy and safety.</p><p><b>METHODS</b>45 patients were randomly divided into two groups. Treatment group given Wenxinkeli (5 g, 3 times a day with warm water) treatment, the control group given adenosine triphosphate, coenzyme A, vitamin C, coenzyme Q10 and other nutrients cardiac drugs, treatment for 4 weeks.</p><p><b>RESULTS</b>The treatment of clinical symptoms, signs and ECG improvement, restoration of enzyme than the control group, there was a significant difference (P < 0.05).</p><p><b>CONCLUSIONS</b>Wenxinkeli ventricular premature treatment of viral myocarditis is effective, and no significant adverse reactions, safety, good.</p>